Cargando…

Retinal Dysfunction in Alzheimer’s Disease and Implications for Biomarkers

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that manifests as cognitive deficits and memory decline, especially in old age. Several biomarkers have been developed to monitor AD progression. Given that the retina and brain share some similarities including features related to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Chunyan, Xu, Jinying, Chen, Yu, Ip, Nancy Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8394950/ https://www.ncbi.nlm.nih.gov/pubmed/34439882 http://dx.doi.org/10.3390/biom11081215

Ejemplares similares

Potential Retinal Biomarkers in Alzheimer’s Disease
por: García-Bermúdez, Mariana Yolotzin, et al.
Publicado: (2023)

Retinal biomarkers for Alzheimer’s disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis
por: Czakó, Cecilia, et al.
Publicado: (2020)

Biomarkers Assessing Endothelial Dysfunction in Alzheimer’s Disease
por: Custodia, Antía, et al.
Publicado: (2023)

Retinal ganglion cell dysfunction in preclinical Alzheimer’s disease: an electrophysiologic biomarker signature
por: Asanad, Samuel, et al.
Publicado: (2021)

Mitochondrial Dysfunction in Alzheimer’s Disease: A Biomarker of the Future?
por: Bell, Simon M., et al.
Publicado: (2021)

Cytokine signaling convergence regulates the microglial state transition in Alzheimer’s disease
por: Lau, Shun-Fat, et al.
Publicado: (2021)

Retinal microvasculature dysfunction is associated with Alzheimer’s disease and mild cognitive impairment
por: Chua, Jacqueline, et al.
Publicado: (2020)

Implication of Hyperhomocysteinemia in Blood Retinal Barrier (BRB) Dysfunction
por: Tawfik, Amany, et al.
Publicado: (2020)

Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease
por: Grammas, Paula
Publicado: (2011)

Olfactory dysfunction in Alzheimer’s disease
por: Zou, Yong-ming, et al.
Publicado: (2016)

Neddylation dysfunction in Alzheimer's disease
por: Chen, Yuzhi, et al.
Publicado: (2012)

Retinal vascular biomarkers for early detection and monitoring of Alzheimer's disease
por: Frost, S, et al.
Publicado: (2013)

Cerebrospinal fluid biomarkers of neurovascular dysfunction in mild dementia and Alzheimer's disease
por: Sweeney, Melanie D, et al.
Publicado: (2015)

Melanopsin retinal ganglion cell loss and circadian dysfunction in Alzheimer's disease (Review)
por: FENG, RUIQI, et al.
Publicado: (2016)

Gut dysbiosis in stroke and its implications on Alzheimer’s disease‐like cognitive dysfunction
por: Cho, Justin, et al.
Publicado: (2021)

Neuropathological and Biomarker Findings in Parkinson’s Disease and Alzheimer’s Disease: From Protein Aggregates to Synaptic Dysfunction
por: Compta, Yaroslau, et al.
Publicado: (2021)

Identification of genetic risk factors in the Chinese population implicates a role of immune system in Alzheimer’s disease pathogenesis
por: Zhou, Xiaopu, et al.
Publicado: (2018)

Autoantibodies in Alzheimer’s disease: potential biomarkers, pathogenic roles, and therapeutic implications
por: Wu, Jianming, et al.
Publicado: (2016)

Cerebral and Retinal Neurovascular Changes: A Biomarker for Alzheimer’s Disease
por: Ravi Teja, Karru Venkata, et al.
Publicado: (2017)

Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?
por: den Haan, Jurre, et al.
Publicado: (2019)

Biomarkers in Alzheimer’s disease
por: Janeiro, Manuel H., et al.
Publicado: (2020)

Identification of Retinal Biomarkers in Alzheimer’s Disease Using Optical Coherence Tomography: Recent Insights, Challenges, and Opportunities
por: Cabrera DeBuc, Delia, et al.
Publicado: (2019)

Multimodal Coherent Imaging of Retinal Biomarkers of Alzheimer’s Disease in a Mouse Model
por: Song, Ge, et al.
Publicado: (2020)

Retinal Degeneration and Alzheimer’s Disease: An Evolving Link
por: Ashok, Ajay, et al.
Publicado: (2020)

Magnetic Resonance Images Implicate That Glymphatic Alterations Mediate Cognitive Dysfunction in Alzheimer Disease
por: Hsu, Jung‐Lung, et al.
Publicado: (2022)

Tear Biomarkers in Alzheimer’s and Parkinson’s Diseases, and Multiple Sclerosis: Implications for Diagnosis (Systematic Review)
por: Król-Grzymała, Angelika, et al.
Publicado: (2022)

The Neurovascular Unit Dysfunction in Alzheimer’s Disease
por: Soto-Rojas, Luis O., et al.
Publicado: (2021)

Insights into T‐cell dysfunction in Alzheimer's disease
por: Dai, Linbin, et al.
Publicado: (2021)

Gut Microbiota: Implications in Alzheimer’s Disease
por: He, Yixi, et al.
Publicado: (2020)

Autophagic/lysosomal dysfunction in Alzheimer’s disease
por: Orr, Miranda E, et al.
Publicado: (2013)

Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease
por: Yamazaki, Yu, et al.
Publicado: (2017)

Implications of Microorganisms in Alzheimer’s Disease
por: Yadav, Pardeep, et al.
Publicado: (2022)

Neurogranin as a Reliable Biomarker for Synaptic Dysfunction in Alzheimer’s Disease
por: Agnello, Luisa, et al.
Publicado: (2021)

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
por: Nilsson, Johanna, et al.
Publicado: (2021)

CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease
por: Janelidze, Shorena, et al.
Publicado: (2018)

Folate and retinal vascular diseases
por: Gu, Jinyue, et al.
Publicado: (2023)

Metabolomics and Biomarkers in Retinal and Choroidal Vascular Diseases
por: Hou, Xiao-Wen, et al.
Publicado: (2022)

The Implication of Androgens in the Presence of Protein Kinase C to Repair Alzheimer’s Disease-Induced Cognitive Dysfunction
por: Amiri, Sara, et al.
Publicado: (2020)

An overview of biomarkers in Alzheimer’s disease
por: Wattamwar, Pandurang R, et al.
Publicado: (2010)

Neuroimaging Biomarkers for Alzheimer’s Disease
por: Márquez, Freddie, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5f3brktks1v3n4pq5rhire0t9t